CIK 0001755237 · Non-accelerated filer<br>Smaller reporting company
Korsana Biosciences, Inc.
Sign in to watch- Ticker
- KRSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 831895370
- Phone
- (781) 516-2325
- Business address
- 203 CRESCENT STREET, BLDGS. #3/3A/4, SUITE 503, WALTHAM, MA, 02453
- Former names
- Cyclerion Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | Wright Christopher I Chief Medical Officer | Sale | −2,637 | $3.99 | $11K | 42,728 |
| 2020-12-28 | Currie Mark G President and CSO | Sale | −20,107 | $3.01 | $61K | 251,648 |
| 2020-11-09 | Busch Andreas Chief Innovation Officer | Purchase | +125,000 | $2.53 | $316K | 254,704 |
| 2020-11-06 | Huyett William Chief Financial Officer | Sale | −3,827 | $2.52 | $10K | 67,590 |
| 2020-11-04 | Busch Andreas Chief Innovation Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-06-16 | Churchwell Kevin Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | CONRADES GEORGE H Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Fanucci Marsha Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Isacson Ole Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Lovell Stephanie Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | Mendelsohn Michael Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-06-16 | SCHULMAN AMY W Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2020-03-31 | Hecht Peter M Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +153,846 | $2.65 | $408K | 153,846 |
| 2020-02-21 | Huyett William Chief Financial Officer | Sale | −3,559 | $5.12 | $18K | 71,417 |
| 2019-12-30 | Currie Mark G President | Sale | −25,000 | $2.48 | $62K | 271,755 |
| 2019-12-27 | Currie Mark G President | Sale | −25,000 | $2.55 | $64K | 296,755 |
| 2019-11-22 | Hecht Peter M Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-22 | Currie Mark G President | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-11-22 | Huyett William Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +75,000 | 75,000 |
Page 4 of 9 · 167 trades